Cargando…
Deficiency of C3a receptor attenuates the development of diabetic nephropathy
OBJECTIVE: Diabetic nephropathy (DN) is the leading cause of chronic kidney disease and end-stage renal disease. Emerging evidence suggests that complement activation is involved in the pathogenesis of DN. The aim of this study was to investigate the pathogenic role of C3a and C3a receptor (C3aR) in...
Autores principales: | Li, Xiao-Qian, Chang, Dong-Yuan, Chen, Min, Zhao, Ming-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861086/ https://www.ncbi.nlm.nih.gov/pubmed/31798904 http://dx.doi.org/10.1136/bmjdrc-2019-000817 |
Ejemplares similares
-
Plasma phenylalanine and tyrosine and their interactions with diabetic nephropathy for risk of diabetic retinopathy in type 2 diabetes
por: Luo, Hui-Huan, et al.
Publicado: (2020) -
Overexpression of lipoic acid synthase gene alleviates diabetic nephropathy of Lepr(db/db) mice
por: Zhao, Yingzheng, et al.
Publicado: (2021) -
Glucagon Receptor Knockout Prevents Insulin-Deficient Type 1 Diabetes in Mice
por: Lee, Young, et al.
Publicado: (2011) -
Nitric Oxide Synthesis Is Reduced in Subjects With Type 2 Diabetes and Nephropathy
por: Tessari, Paolo, et al.
Publicado: (2010) -
Therapeutic Impact of Leptin on Diabetes, Diabetic Complications, and Longevity in Insulin-Deficient Diabetic Mice
por: Naito, Masaki, et al.
Publicado: (2011)